BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25409167)

  • 1. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial.
    Park SW; Chung MJ; Oh TG; Park JY; Bang S; Park SW; Song SY
    Endoscopy; 2015 Jan; 47(1):33-9. PubMed ID: 25409167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
    Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
    Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study.
    Geraci G; Palumbo VD; D'Orazio B; Maffongelli A; Fazzotta S; Lo Monte AI
    Clin Ter; 2019; 170(5):e332-e336. PubMed ID: 31612188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Khoshbaten M; Khorram H; Madad L; Ehsani Ardakani MJ; Farzin H; Zali MR
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e11-6. PubMed ID: 17683501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
    Lua GW; Muthukaruppan R; Menon J
    Dig Dis Sci; 2015 Oct; 60(10):3118-23. PubMed ID: 25757446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
    Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S
    Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
    Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac Does Not Reduce the Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Low-Risk Units.
    Rainio M; Lindström O; Udd M; Louhimo J; Kylänpää L
    J Gastrointest Surg; 2017 Aug; 21(8):1270-1277. PubMed ID: 28374181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitroglycerin as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.
    Tomoda T; Kato H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Matsumoto K; Yamamoto N; Horiguchi S; Tsutsumi K; Okada H
    Acta Med Okayama; 2016 Octoaber; 70(5):405-408. PubMed ID: 27777436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac is associated with a reduced incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: results from a Danish cohort study.
    Leerhøy B; Nordholm-Carstensen A; Novovic S; Hansen MB; Jørgensen LN
    Pancreas; 2014 Nov; 43(8):1286-90. PubMed ID: 25003219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients.
    Katoh T; Kawashima K; Fukuba N; Masuda S; Kobatake H; Masaki K; Araki Y; Kawano K; Nishi K; Takenaka M; Ishihara S; Kinoshita Y
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1247-1253. PubMed ID: 31788849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial.
    Cheon YK; Cho KB; Watkins JL; McHenry L; Fogel EL; Sherman S; Schmidt S; Lazzell-Pannell L; Lehman GA
    Gastrointest Endosc; 2007 Dec; 66(6):1126-32. PubMed ID: 18061712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography.
    Tomoda T; Kato H; Ueki T; Akimoto Y; Hata H; Fujii M; Harada R; Ogawa T; Wato M; Takatani M; Matsubara M; Kawai Y; Okada H
    Gastroenterology; 2019 May; 156(6):1753-1760.e1. PubMed ID: 30772342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial.
    Otsuka T; Kawazoe S; Nakashita S; Kamachi S; Oeda S; Sumida C; Akiyama T; Ario K; Fujimoto M; Tabuchi M; Noda T
    J Gastroenterol; 2012 Aug; 47(8):912-7. PubMed ID: 22350703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.